Literature DB >> 33622207

The Role of Acupuncture on the Gut-Brain-Microbiota Axis in Irritable Bowel Syndrome.

Kiangyada Yaklai1,2, Sintip Pattanakuhar1,3, Nipon Chattipakorn1,4, Siriporn C Chattipakorn1,5.   

Abstract

Irritable bowel syndrome (IBS) is a chronic dysfunction of the gastrointestinal tract, commonly characterized by abdominal pain or abdominal discomfort. These symptoms can substantially reduce the quality of life and work productivity of the patients. The exact pathogenesis of IBS remains unclear, as it has become apparent that multiple pathways are activated in the condition, including inflammation, immunology, neurology and psychology. Recent evidence has shown that symptoms in IBS are related to the dysfunction of the nervous system, particularly the viscerosomatic pathway, through immune-to-brain communication. The potential link between brain-gut relationships is gut microbiota. The management of IBS mostly focuses on symptomatically treating the patients. There are a wide range of standard treatments, including pharmacological to psychological interventions which are effective in some patients. Therefore, a combination of therapies including both standard and complimentary treatments, including Traditional Chinese Medicine (TCM) such as acupuncture, have been used in treating IBS patients. Several in vivo and clinical studies have demonstrated the efficacy of acupuncture in treating IBS. Increasing attention has been paid to research regarding the action mechanisms of acupuncture for IBS. This paper summarizes and discusses the possible mechanisms associated with acupuncture on the pathophysiology of IBS, including gastrointestinal (GI) motility, visceral hypersensitivity, the immune system, neurotransmitters, and the brain-gut axis. The results fromin vivo and clinical studies have been included. In addition, the effects of acupuncture on gut microbiota in IBS are included and any contradictory findings are deliberated.

Entities:  

Keywords:  Acupuncture; Gut–Brain Axis; Irritable Bowel Syndrome; Microbiota; Review

Year:  2021        PMID: 33622207     DOI: 10.1142/S0192415X21500154

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  7 in total

1.  Medicinal Plants Used for Abdominal Discomfort - Information from Cancer Patients and Medical Students.

Authors:  Soeren Klaus Buentzel; Jutta Huebner; Judith Buentzel; Oliver Micke
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

2.  A Comparison Study of the Effect on IBS-D Rats among Ginger-Partitioned Moxibustion, Mild Moxibustion, and Laser Moxibustion.

Authors:  Chao Sun; Xiaofeng Yang; Sirui Xie; Ziqin Zhou; Guoliang Yu; Shangsheng Feng; Jingyu Zhao; Jiangtao Wu; Changchun Ji
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-17       Impact factor: 2.629

3.  Moxibustion for diarrhea in COVID-19: A protocol for systematic review and meta-analysis.

Authors:  Ningning Liu; Yingxue Xu; Dongbin Zhang; Lianzhu Wang; Yi Hou; Jiafu Ji
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

4.  External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.

Authors:  Xiuxiu Wei; Yongtian Wen; Yuchen Wei; Xu Liang; Xiangxue Ma; Beihua Zhang; Xudong Tang
Journal:  Front Med (Lausanne)       Date:  2022-08-09

5.  Effects and Mechanisms of Acupuncture on Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review.

Authors:  Gezhi Zhang; Tao Zhang; Zeng Cao; Zijing Tao; Tianhao Wan; Mengxi Yao; Xiaolan Su; Wei Wei
Journal:  Front Neurosci       Date:  2022-07-15       Impact factor: 5.152

6.  Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial.

Authors:  Ling-Yu Qi; Jing-Wen Yang; Shi-Yan Yan; Yan-Fen She; Hui Hu; Ying Li; Li-Li Chi; Bang-Qi Wu; Jian-Feng Tu; Li-Qiong Wang; Cun-Zhi Liu
Journal:  Trials       Date:  2022-08-26       Impact factor: 2.728

7.  Moxibustion for diarrhea-predominant irritable bowel syndrome: A protocol for systematic review and network meta-analysis.

Authors:  Tiantian Dong; Xuhao Li; Xin Ma; Xiqing Xue; Yi Hou; Yuanxiang Liu; Jiguo Yang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.